Advertisement
Advertisement
U.S. Markets close in 2 hrs 21 mins
Advertisement
Advertisement
Advertisement
Advertisement

NexgenRx Inc. (NEGXF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.20210.0000 (0.00%)
As of 03:30PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.2021
Open0.2022
BidN/A x N/A
AskN/A x N/A
Day's Range0.2021 - 0.2021
52 Week Range0.0110 - 0.3217
Volume16,000
Avg. Volume258
Market Cap17.428M
Beta (5Y Monthly)0.14
PE Ratio (TTM)9.62
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.01 (132.39%)
Ex-Dividend DateSep 30, 2022
1y Target EstN/A
  • ACCESSWIRE

    NexgenRx Announces Q3 2022 Financial Results with Continued Revenue Growth, Positive EBITDA and Free Cash Flow

    NEXGENRX INC.("NexgenRx" or the "Company") is pleased to announce its interim financial results for the third quarter ended September 30, 2022, highlighted by continued revenue growth, positive EBIDTA and increased free cash flow. During Q3 2022, the Company showed revenue growth of 15.81% over the same period last year. Revenue for the third quarter was $3,317,358 and $9,401,460 year-to-date.

  • ACCESSWIRE

    Nexgenrx Announces Declaration Of Dividend

    NEXGENRX INC.("NexgenRx" or the "Company") is pleased to announce that a dividend in the amount of one-half of one cent per share ($0.005) has been declared in respect of all of its outstanding common shares and series 1 preferred shares. This dividend will be payable on or before October 10, 2022 to all shareholders of record as at the close of business on October 3, 2022.

  • ACCESSWIRE

    NexgenRx Announces Q2 2022 Financial Results with Continued Revenue Growth, Positive EBITDA and Increased Free Cash Flow

    NEXGENRX INC.("NexgenRx" or the "Company") is pleased to announce its interim financial results for the second quarter ended June 30, 2022, highlighted by continued revenue growth, positive EBIDTA and increased free cash flow. The Company's Q2 revenue was 12.73% higher compared to the same period last year. Revenue for the second quarter was $3,113,202 and $6,287,078 year to date.

Advertisement
Advertisement